HCPCS code Q5121 — Inj. avsola, 10 mg. Status: Active. Effective Oct 1, 2023. Source: CMS HCPCS Level II.

Q5121

Active

Inj. avsola, 10 mg

Injection, infliximab-axxq, biosimilar, (avsola), 10 mg

Category: Temporary
Section: Q-codes: Temporary Codes
Effective: Oct 1, 2023
Code type: alphanumeric
OPPS Status: K — Non-pass-through drugs and biologicals
OPPS APC: 9381

MUE — Medically Unlikely Edits

Maximum units of Q5121 Medicare will pay for one beneficiary on one date of service. Claims exceeding the MUE are denied or returned for review.

Service Type Max Units / Day
Outpatient Hospital 150
Practitioner Services 150

Source: CMS Medicare NCCI Medically Unlikely Edits

NDC Crosswalk

National Drug Codes (NDCs) mapped to this HCPCS code.

NDC Drug Name
55513-0670-01 Avsola

Change History

Quarterly changes published by CMS. Revisions may affect the code description, coverage, or rate — review each quarter's changes before submitting claims.

  • New Code 2023-Q4
    Inj. avsola, 10 mg